EPISODE · Oct 4, 2023 · 43 MIN
Ep 31: Mark Cuban on Disrupting PBMs, Staying Curious & Using AI to Avoid NBA Fines
from Vital Signs with Jacob Effron and Nikhil Krishnan · host Mark Cuban, Nikhil Krishnan, Jacob Effron
Jacob and Nikhil sit down with Mark Cuban to discuss his pharmaceutical startup, The Mark Cuban Cost Plus Drug Company. They discuss why Mark entered the healthcare industry, competing on price, staying curious, and the future of AI. (0:00) intro (1:05) Mark’s journey into healthcare (3:57) how the Mark Cuban Cost Plus Drug Company works (7:51) B2B angle and disrupting PBMs(12:51) getting into biologics and biosimilars (24:46) manufacturing drugs (27:11) how much of a role can technology play in healthcare? (33:06) why Mark doesn’t put his name on buildings (35:35) over-hyped/under-hyped (40:08) policy changes that could improve healthcare (41:17) Mark’s best cameo
Embed this episode
What this episode covers
Jacob and Nikhil sit down with Mark Cuban to discuss his pharmaceutical startup, The Mark Cuban Cost Plus Drug Company. They discuss why Mark entered the healthcare industry, competing on price, staying curious, and the future of AI.
NOW PLAYING
Ep 31: Mark Cuban on Disrupting PBMs, Staying Curious & Using AI to Avoid NBA Fines
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.